EXELDERM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Exelderm, and what generic alternatives are available?
Exelderm is a drug marketed by Journey and is included in two NDAs.
The generic ingredient in EXELDERM is sulconazole nitrate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the sulconazole nitrate profile page.
Summary for EXELDERM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 1,394 |
| Drug Prices: | Drug price information for EXELDERM |
| What excipients (inactive ingredients) are in EXELDERM? | EXELDERM excipients list |
| DailyMed Link: | EXELDERM at DailyMed |
Pharmacology for EXELDERM
| Drug Class | Azole Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for EXELDERM
US Patents and Regulatory Information for EXELDERM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | EXELDERM | sulconazole nitrate | CREAM;TOPICAL | 018737-001 | Feb 28, 1989 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Journey | EXELDERM | sulconazole nitrate | SOLUTION;TOPICAL | 018738-001 | Aug 30, 1985 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EXELDERM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Journey | EXELDERM | sulconazole nitrate | SOLUTION;TOPICAL | 018738-001 | Aug 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EXELDERM
See the table below for patents covering EXELDERM around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | S5910344 | ⤷ Try a Trial | |
| Malaysia | 8000270 | 1-[(BETA)-(R-THIO) PHENETHYL] IMIDAZOLES AND DERIVATIVES THEREOF | ⤷ Try a Trial |
| Yugoslavia | 226981 | ⤷ Try a Trial | |
| Denmark | 155283 | ⤷ Try a Trial | |
| Japan | S5157828 | SHINKINMATAHA SAIKINNO HATSUIKUOSOSHISURUSOSEIBUTSUOYOBI HOHONARABINI SONOKATSUSEISEIBUNNO SEIZOHO | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
